PEIMF yields 2486.33% · PFE yields 6.13%● Live data
📍 PEIMF pulled ahead of the other in Year 1
Combined, PEIMF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PEIMF + PFE for your $10,000?
Power Minerals Limited engages in the exploration and development of mineral projects in Australia and Argentina. It primarily explores for lithium, copper, nickel, cobalt, gold, and kaolin deposits. The company holds 100% interest in the Salta Lithium Brine project that comprises 11 leases covering an area of 23,796 hectares located in Salta Province, Argentina; and the Musgrave project that consists of two exploration licenses and eight exploration license applications covering an area of 14,618 square kilometers located in the Musgrave Province, South Australia. It also holds interests in the Eyre Peninsula Kaolin project that consists of three exploration licenses covering an area of 1,413 square kilometers located in South Australia; and the Santa Ines copper-gold project that consists of four mining leases covering 61.4 square kilometers located in Argentina. The company was formerly known as PepinNini Minerals Limited and changed its name to Power Minerals Limited in June 2022. Power Minerals Limited was incorporated in 2002 and is based in Kent Town, Australia.
Full PEIMF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.